TickerFiles

Barinthus Biotherapeutics plc. 10-Q filing

Filed 2025-11-07 · Report date 2025-09-30 · 2025

View Original SEC Filing

Filing metadata

Accession number
0001828185-25-000072
Form type
10-Q
CIK
0001828185
Primary document
https://www.sec.gov/Archives/edgar/data/1828185/000182818525000072/brns-20250930.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Barinthus Biotherapeutics plc..

Reported financial metrics

MetricCurrentPriorChange
Revenue$0--
Operating Income$-59.0M--
Net Income$-55.3M--
Eps Basic-1.37--
Eps Diluted-1.37--
Cash And Equivalents$74.3M--
Total Assets$109.2M--
Total Liabilities$24.6M--
Shareholders Equity$84.5M--
Operating Cash Flow$-43.7M--
Capital Expenditures$37,000--